BR100 Increased By (0.44%)
BR30 Increased By (1.39%)
KSE100 Increased By (0.62%)
KSE30 Increased By (0.61%)
BECO 5.49 No Change ▼ 0.00 (0%)
BML 56.00 Decreased By ▼ -0.76 (-1.34%)
BOP 35.41 Increased By ▲ 0.29 (0.83%)
CNERGY 8.20 Increased By ▲ 0.05 (0.61%)
DCL 11.55 Increased By ▲ 0.04 (0.35%)
FCCL 58.15 Increased By ▲ 1.40 (2.47%)
FCSC 5.15 No Change ▼ 0.00 (0%)
FFL 17.90 Increased By ▲ 0.02 (0.11%)
FNEL 1.25 No Change ▼ 0.00 (0%)
HUMNL 11.10 Decreased By ▼ -0.02 (-0.18%)
KEL 8.56 Increased By ▲ 0.14 (1.66%)
KOSM 6.75 Increased By ▲ 0.17 (2.58%)
MLCF 105.65 Increased By ▲ 2.35 (2.27%)
NBP 202.10 Increased By ▲ 1.92 (0.96%)
PACE 11.28 Decreased By ▼ -0.01 (-0.09%)
PAEL 44.42 Increased By ▲ 0.95 (2.19%)
PIAHCLA 28.66 Increased By ▲ 1.17 (4.26%)
PIBTL 18.75 Increased By ▲ 1.05 (5.93%)
PPL 248.10 Increased By ▲ 3.78 (1.55%)
PRL 35.35 Decreased By ▼ -0.08 (-0.23%)
PTC 66.15 Increased By ▲ 0.80 (1.22%)
SEARL 94.95 Increased By ▲ 1.63 (1.75%)
SSGC 32.04 Decreased By ▼ -0.90 (-2.73%)
TELE 8.93 Increased By ▲ 0.02 (0.22%)
THCCL 66.65 Decreased By ▼ -0.07 (-0.1%)
TPLP 10.76 Decreased By ▼ -0.07 (-0.65%)
TREET 25.22 Increased By ▲ 0.10 (0.4%)
TRG 64.21 Decreased By ▼ -0.69 (-1.06%)
WAVES 10.85 Decreased By ▼ -0.08 (-0.73%)
WTL 1.27 Increased By ▲ 0.02 (1.6%)
Business & Finance

GSK Consumer Health Pakistan appoints Farhan Muhammad Haroon as CEO

*The company informed that the incoming Farhan Muhammad Haroon will assume the charge of the company effective 1 April 2021.
Published February 8, 2021 Updated February 8, 2021 05:04pm

The Board of Directors of Pakistan’s pharmaceutical giant, GlaxoSmithKline (GSK) Consumer Healthcare Pakistan Limited has appointed Farhan Muhammad Haroon as the Chief Executive Officer and Executive Director of the Company in place of Sohail Ahmed Matin.

“This is to inform shareholders that after an esteemed and outstanding career, Sohail Ahmed Matin will be retiring as the Chief Executive Officer of GSK Consumer Healthcare Pakistan Limited (Company) effective 31 March 2021,” said the company in a statement.

GSK informed that the incoming Farhan Muhammad Haroon will assume the charge of the company effective 1 April 2021.

“Haroon has been with GSK for over 10 years. His last assignment was Audit Account Director, of the GSK Global Audit & Assurance function. Previously Haroon also served as the Finance Director and a member of the Board of Directors of the Company,” said GSK.

“During his time with GSK, Haroon has led various key local and above country restructurings, M&As and change management projects. He has performed multiple leadership roles in Finance, Distributor Management, E2E Supply Chain, In-Country Shared Services and played key business partnering roles with Supply Chain, Legal, HR and Site operations, through which he has contributed to the success of the Company,” it added.

Comments

Comments are closed for this article.